Inhaled and Systemic Corticosteroid Therapies: Do They Contribute to Inspiratory Muscle Weakness in Asthma?

Publisher： Karger

E-ISSN： 1423-0356|66|4|332-337

ISSN： 0025-7931

Source： Respiration, Vol.66, Iss.4, 1999-08, pp. : 332-337

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Usefulness of Inspiratory Flow Rate during Inhalation Corticosteroid Therapy in Asthma

By  

Respiration, Vol. 78, Iss. 4, 2009-05 ,pp. : 387-392

Karger

Access to resources Recommend Favorite

Effects of Salmeterol in Patients with Persistent Asthma Receiving Inhaled Corticosteroid plus Theophylline

By  

Respiration, Vol. 74, Iss. 6, 2006-09 ,pp. : 611-616

Karger

Access to resources Recommend Favorite

Changes in Airway Inflammation and Hyperresponsiveness after Inhaled Corticosteroid Cessation in Allergic Asthma

By  

International Archives of Allergy and Immunology, Vol. 152, Iss. 1, 2010-06 ,pp. : 41-46

Karger

Access to resources Recommend Favorite

Asthma Control following Initial Inhaled Corticosteroid Monotherapy in Mild to Moderate Asthma: A 4- to 8-Week Observational Study

By  

Respiration, Vol. 73, Iss. 5, 2006-09 ,pp. : 617-622

Karger

Access to resources Recommend Favorite

Mometasone furoate dry powder inhaler: a once-daily inhaled corticosteroid for the treatment of persistent asthma

By Karpel Jill P.   Nelson Harold  

Current Medical Research and Opinion, Vol. 23, Iss. 11, 2007-11 ,pp. : 2897-2911

Informa Healthcare

Access to resources Recommend Favorite